Annika Sanfridson

1.0k total citations
17 papers, 710 citations indexed

About

Annika Sanfridson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Annika Sanfridson has authored 17 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Annika Sanfridson's work include Cancer Immunotherapy and Biomarkers (5 papers), HIV Research and Treatment (3 papers) and Immune Cell Function and Interaction (2 papers). Annika Sanfridson is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), HIV Research and Treatment (3 papers) and Immune Cell Function and Interaction (2 papers). Annika Sanfridson collaborates with scholars based in United States, Sweden and Denmark. Annika Sanfridson's co-authors include Carolyn A. Doyle, Bryan R. Cullen, Janet Ottinger, R. Edward Benson, María E. Cárdenas, Joseph Heitman, Susan Hester, N. Shane Cutler, Eszter Nagy and Tamás Henics and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Annika Sanfridson

14 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika Sanfridson United States 10 318 260 251 153 120 17 710
Laurent Chêne France 16 234 0.7× 264 1.0× 317 1.3× 87 0.6× 113 0.9× 24 780
Jean-Philippe Belzile Canada 11 306 1.0× 241 0.9× 270 1.1× 123 0.8× 188 1.6× 13 703
Adrianne D. Gladden United States 9 388 1.2× 272 1.0× 309 1.2× 198 1.3× 155 1.3× 9 803
Brendan Bell Canada 15 230 0.7× 162 0.6× 687 2.7× 131 0.9× 63 0.5× 30 938
Núria Gonzàlez Spain 17 328 1.0× 258 1.0× 204 0.8× 168 1.1× 85 0.7× 28 664
Xiuzhen Yan United States 12 117 0.4× 137 0.5× 257 1.0× 118 0.8× 191 1.6× 13 577
Hong Shang China 17 203 0.6× 209 0.8× 273 1.1× 185 1.2× 201 1.7× 67 841
Rebekah L. Zinn United States 8 260 0.8× 119 0.5× 438 1.7× 196 1.3× 208 1.7× 10 909
Emmanuel Agbottah United States 17 379 1.2× 166 0.6× 343 1.4× 227 1.5× 85 0.7× 19 624
Cheol‐Hee Yoon South Korea 14 124 0.4× 227 0.9× 386 1.5× 85 0.6× 94 0.8× 34 699

Countries citing papers authored by Annika Sanfridson

Since Specialization
Citations

This map shows the geographic impact of Annika Sanfridson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Sanfridson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Sanfridson more than expected).

Fields of papers citing papers by Annika Sanfridson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Sanfridson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Sanfridson. The network helps show where Annika Sanfridson may publish in the future.

Co-authorship network of co-authors of Annika Sanfridson

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Sanfridson. A scholar is included among the top collaborators of Annika Sanfridson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Sanfridson. Annika Sanfridson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Østergaard, Søren, Carsten Jessen, Johan F. Paulsson, et al.. (2025). Variant screening of PYY 3–36 leads to potent long-acting PYY analogs with superior Y 2 receptor selectivity. Science Translational Medicine. 17(791). eadq6392–eadq6392. 3 indexed citations
3.
Cutsem, Eric Van, Joëlle Collignon, Rikke Løvendahl Eefsen, et al.. (2024). Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer. Clinical Cancer Research. 30(23). 5293–5303. 2 indexed citations
4.
Cutsem, Eric Van, Jashodeep Datta, Manuel Hidalgo, et al.. (2024). Abstract C002: Interleukin-1 receptor accessory protein (IL1RAP) overexpression is associated with worse prognosis in PDAC and is targetable by nadunolimab. Cancer Research. 84(2_Supplement). C002–C002.
5.
Cohen, Roger B., Antonio Jimeno, Marie Öhman, et al.. (2024). 1012P Safety, tolerability, and efficacy of nadunolimab in combination with pembrolizumab in patients with solid tumors. Annals of Oncology. 35. S686–S686.
6.
Cutsem, Eric Van, Joëlle Collignon, Rikke Løvendahl Eefsen, et al.. (2023). Abstract 2172: Tumor IL1RAP levels and reduction in serum biomarkers correlate with response in PDAC patients treated with nadunolimab, an anti-IL1RAP monoclonal antibody, in combination with gemcitabine and nab-paclitaxel. Cancer Research. 83(7_Supplement). 2172–2172. 2 indexed citations
7.
Enoksson, Mari, Erika J. Martin, Mette S. Jensen, et al.. (2019). Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets. Journal of Thrombosis and Haemostasis. 18(1). 104–113. 4 indexed citations
8.
Christoffersen, Berit Østergaard, Rikke Bjerring Skyggebjerg, Anne Bugge, et al.. (2019). Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs. International Journal of Obesity. 44(2). 447–456. 24 indexed citations
9.
Stevens, Tim, Maria Lindahl, Andrew Churg, et al.. (2011). AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase. Journal of Pharmacology and Experimental Therapeutics. 339(1). 313–320. 95 indexed citations
10.
Sanfridson, Annika, et al.. (2006). TAB1 modulates IL-1α mediated cytokine secretion but is dispensable for TAK1 activation. Cellular Signalling. 19(3). 646–657. 17 indexed citations
11.
Sanfridson, Annika, et al.. (2005). Inflammatory Pathway Analysis Using a High Content Screening Platform. Assay and Drug Development Technologies. 3(3). 261–271. 32 indexed citations
12.
Cárdenas, María E., Annika Sanfridson, N. Shane Cutler, & Joseph Heitman. (1998). Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends in biotechnology. 16(10). 427–433. 76 indexed citations
13.
Sanfridson, Annika, Susan Hester, & Carolyn A. Doyle. (1997). Nef proteins encoded by human and simian immunodeficiency viruses induce the accumulation of endosomes and lysosomes in human T cells. Proceedings of the National Academy of Sciences. 94(3). 873–878. 56 indexed citations
14.
Henics, Tamás, Annika Sanfridson, B. JoNell Hamilton, Eszter Nagy, & William F. C. Rigby. (1994). Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins.. Journal of Biological Chemistry. 269(7). 5377–5383. 87 indexed citations
15.
Kinch, Michael S., Annika Sanfridson, & Carolyn A. Doyle. (1994). The protein tyrosine kinase p56lck regulates cell adhesion mediated by CD4 and major histocompatibility complex class II proteins.. The Journal of Experimental Medicine. 180(5). 1729–1739. 12 indexed citations
16.
Sanfridson, Annika, Bryan R. Cullen, & Carolyn A. Doyle. (1994). The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells.. Journal of Biological Chemistry. 269(6). 3917–3920. 44 indexed citations
17.
Benson, R. Edward, Annika Sanfridson, Janet Ottinger, Carolyn A. Doyle, & Bryan R. Cullen. (1993). Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.. The Journal of Experimental Medicine. 177(6). 1561–1566. 256 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026